UCB
Jennifer Trevett has extensive legal experience in the healthcare and pharmaceutical sectors, currently serving as Vice President and Head of Legal for Global Immunology at UCB since November 2010. Trevett has progressed rapidly within the organization, providing strategic leadership for the legal affairs of the Global Immunology Business across US, EU, and international markets. Prior to UCB, Trevett held senior legal roles at Cadence Pharmaceuticals, Kimberly-Clark, GSK, and Cardinal Health, where responsibilities included overseeing commercial, regulatory, and compliance matters, drafting contracts, and providing legal counsel to various departments. Trevett holds a Juris Doctor degree from the University at Buffalo and a Bachelor of Science degree from Penn State University.
This person is not in any teams
This person is not in any offices
UCB
45 followers
Ucb SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology.